Chronic pain is one of the most common, debilitating and costly conditions affecting individuals of all ages in the United States. The etiology and pathogenesis of chronic pain remain unclear, although a number of contributory factors have been identified under the benefits of delta 8 gummies usage. In addition to obvious tissue damage, a few other factors include hypersensitivity to stimuli, genetic factors such as changes in gene expression or mutations in certain genes, and abnormal regulation of endogenous opioids.
Delta-8-thc gummies are an efficient way for patients to take their medication because they can be taken at any time during the day. The amount of THC used in these gummies is the equivalent of one hit. They have an almost immediate effect and give patients a great feeling of euphoria after meditating on the benefits they are giving their patients.
Rationale and Objectives
Chronic pain is one of the most common, debilitating and costly conditions affecting individuals of all ages in the United States. The etiology and pathogenesis of chronic pain remain unclear, although a number of contributory factors have been identified. In addition to obvious tissue damage, a few other factors include hypersensitivity to stimuli, genetic factors such as changes in gene expression or mutations in certain genes, and abnormal regulation of endogenous opioids. Delta-8-THC is a cannabinoid agonist that has been found to attenuate pain sensation and help reduce the development of chronic pain issues.
Delta-8-THC is a compound very similar in chemical structure to delta-9-THC and other cannabinoids that naturally occur in the body, but it lacks some of the psychotropic properties of the other cannabinoids. Delta-8-THC mimics the natural endocannabinoid system found in mammals and interacts with CB1 receptors. This is why it was named delta-8 because delta 9 fatty acid binds to CB2 receptors; however, delta 8 is a nonpsychoactive agonist that interacts with CB1 receptors.
History of Delta-8 gummies
Delta 8 gummies are a new way to deliver medicine. The person is getting the same amount of medicine, it’s just in a different form of ingestion. There have been cannabis gummy bears before, but this is the first time that delta-8 is used in medical cannabis and not in industrial hemp. (Gummies) were for kids’ candy and things like that, so it caught people by surprise when it first came out. I think it took some patients by surprise. It was new, but after a few more years, people got used to it. It was no longer weird, no longer taboo.
The gummies were first approved for use by the Food and Drug Administration in November 2013. The approval process took three years, as the FDA had to do an analysis of the data from clinical studies before approving them. The analysis found that pain patients who took delta-8 gummies experienced a slight reduction in pain, but they also experienced some side effects that were “similar or identical” to those of other medicines prescribed for cancer and HIV/AIDS.
